These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28970391)

  • 1. Restrictions to Pharmacy Ownership and Vertical Integration in Estonia-Perception of Different Stakeholders.
    Gross M; Volmer D
    Pharmacy (Basel); 2016 Apr; 4(2):. PubMed ID: 28970391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary health care policy and vision for community pharmacy and pharmacists in Estonia.
    Sepp K; Tuula A; Bobrova V; Volmer D
    Pharm Pract (Granada); 2021; 19(2):2404. PubMed ID: 34035870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in public satisfaction with community pharmacy services in Tartu, Estonia, between 1993 and 2005.
    Volmer D; Bell JS; Janno R; Raal A; Hamilton DD; Airaksinen MS
    Res Social Adm Pharm; 2009 Dec; 5(4):337-46. PubMed ID: 19962677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholders' expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview study.
    Wisell K; Winblad U; Sporrong SK
    BMC Health Serv Res; 2016 Aug; 16(1):379. PubMed ID: 27519573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership.
    Gallone EL; Ravetto Enri L; Pignata I; Baratta F; Brusa P
    Health Policy; 2020 Dec; 124(12):1281-1286. PubMed ID: 32994057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing purchase of and counselling about prescription and OTC medicines at community pharmacies in Tallinn, Estonia.
    Villako P; Volmer D; Raal A
    Acta Pol Pharm; 2012; 69(2):335-40. PubMed ID: 22568049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy Practice and Education in Estonia.
    Volmer D; Sepp K; Raal A; Atkinson J
    Pharmacy (Basel); 2019 Jul; 7(3):. PubMed ID: 31295797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary health care pharmacists and vision for community pharmacy and pharmacists in Chile.
    Martínez-Mardones F; Ahumada-Canale A; Gonzalez-Machuca L; Plaza-Plaza JC
    Pharm Pract (Granada); 2020; 18(3):2142. PubMed ID: 32922575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of community pharmacies in counseling of personal medical devices and drug-delivery products in Estonia.
    Volmer D; Ratassepp T; Shagandina A; Turunen J; Ahonen R; Heinämäki J
    Expert Rev Med Devices; 2015 Jul; 12(4):487-93. PubMed ID: 26037824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple policy approaches in improving community pharmacy practice: the case in Indonesia.
    Hermansyah A; Sainsbury E; Krass I
    BMC Health Serv Res; 2018 Jun; 18(1):449. PubMed ID: 29898723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Raison D'être for the Community Pharmacy and the Community Pharmacist in Sweden: A Qualitative Interview Study.
    Wisell K; Sporrong SK
    Pharmacy (Basel); 2015 Dec; 4(1):. PubMed ID: 28970376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of Estonian consumer expectations from the pharmacy service and a comparison with the opinions of pharmacists.
    Villako P; Raal A
    Pharm World Sci; 2007 Oct; 29(5):546-50. PubMed ID: 17497224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profession Driven Improvement of the Quality of Pharmacy Practice-Implementation of Community Pharmacy Services Quality Guidelines in Estonia.
    Sepp K; Cavaco AM; Raal A; Volmer D
    Healthcare (Basel); 2021 Jun; 9(7):. PubMed ID: 34206788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the impact of the universal healthcare coverage programme on community pharmacy practice.
    Hermansyah A; Sainsbury E; Krass I
    Health Soc Care Community; 2018 Mar; 26(2):e249-e260. PubMed ID: 28990292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principles of person-centredness in quality patient care-Evaluation of the Community Pharmacy Services Quality Guidelines in Estonia.
    Sepp K; Cavaco A; Volmer D
    Int J Health Plann Manage; 2022 Dec; 37 Suppl 1(Suppl 1):101-114. PubMed ID: 36017785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploration of the utility of appraisals for the revalidation of pharmacy professionals in community pharmacy in Great Britain.
    Jee SD; Jacobs S; Schafheutle EI; Elvey R; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):155-65. PubMed ID: 23517657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy ownership in Canada: implications for the authority and autonomy of community pharmacy managers.
    Dobson RT; Perepelkin J
    Res Social Adm Pharm; 2011 Dec; 7(4):347-58. PubMed ID: 21272538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.